Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib trial of cobiprostone oral spray

Trial Profile

Phase Ib trial of cobiprostone oral spray

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Apr 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cobiprostone (Primary)
  • Indications Stomatitis
  • Focus Adverse reactions
  • Sponsors Sucampo Pharmaceuticals

Most Recent Events

  • 10 Apr 2014 New trial record
  • 01 Mar 2014 Status changed from recruiting to completed, according to a Sucampo Pharmaceuticals company's SEC filing 10-K, March 2015 (Link : https://www.sec.gov/Archives/edgar/data/1365216/000117184315001318/f10k_030515.htm ).
  • 05 Nov 2013 According to a Sucampo Pharmaceuticals media release, company initiates the study in Oct 2013.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top